Philadelphia Trust Company’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-58,095
| Closed | -$1.79M | – | 232 |
|
|
2023
Q2 | $1.79M | Sell |
58,095
-155,335
| -73% | -$4.78M | 0.17% | 94 |
|
|
2023
Q1 | $7.69M | Sell |
213,430
-6,510
| -3% | -$235K | 0.78% | 34 |
|
|
2022
Q4 | $8.69M | Sell |
219,940
-8,310
| -4% | -$328K | 0.93% | 26 |
|
|
2022
Q3 | $9.17M | Sell |
228,250
-3,295
| -1% | -$132K | 1.04% | 25 |
|
|
2022
Q2 | $9.73M | Buy |
231,545
+1,860
| +0.8% | +$78.2K | 1% | 27 |
|
|
2022
Q1 | $8.95M | Buy |
229,685
+1,750
| +0.8% | +$68.2K | 0.71% | 39 |
|
|
2021
Q4 | $9.08M | Sell |
227,935
-3,370
| -1% | -$134K | 0.66% | 45 |
|
|
2021
Q3 | $8.36M | Buy |
231,305
+58,280
| +34% | +$2.11M | 0.62% | 48 |
|
|
2021
Q2 | $7.09M | Buy |
173,025
+550
| +0.3% | +$22.5K | 0.49% | 54 |
|
|
2021
Q1 | $7.52M | Sell |
172,475
-500
| -0.3% | -$21.8K | 0.58% | 44 |
|
|
2020
Q4 | $8.66M | Buy |
172,975
+18,725
| +12% | +$937K | 0.71% | 41 |
|
|
2020
Q3 | $6.49M | Buy |
+154,250
| New | +$6.49M | 0.63% | 41 |
|